Chemoinformaics analysis of 5-(PENTADECA-8,11,14-TRIEN-1-YL)RESORCINOL
| Molecular Weight | 314.469 | nRot | 12 |
| Heavy Atom Molecular Weight | 284.229 | nRig | 9 |
| Exact Molecular Weight | 314.225 | nRing | 1 |
| Solubility: LogS | -4.023 | nHRing | 0 |
| Solubility: LogP | 6.616 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 56.6778 |
| nHD | 2 | BPOL | 30.0962 |
| QED | 0.363 |
| Synth | 2.736 |
| Natural Product Likeliness | 1.535 |
| NR-PPAR-gamma | 0.945 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -4.766 |
| MDCK | 0.0000197 |
| BBB | 0.188 |
| PPB | 0.991308 |
| VDSS | 2.341 |
| FU | 0.0130046 |
| CYP1A2-inh | 0.977 |
| CYP1A2-sub | 0.158 |
| CYP2c19-inh | 0.946 |
| CYP2c19-sub | 0.059 |
| CYP2c9-inh | 0.802 |
| CYP2c9-sub | 0.979 |
| CYP2d6-inh | 0.963 |
| CYP2d6-sub | 0.855 |
| CYP3a4-inh | 0.844 |
| CYP3a4-sub | 0.083 |
| CL | 9.534 |
| T12 | 0.771 |
| hERG | 0.011 |
| Ames | 0.037 |
| ROA | 0.016 |
| SkinSen | 0.971 |
| Carcinogencity | 0.138 |
| EI | 0.986 |
| Respiratory | 0.887 |
| NR-Aromatase | 0.622 |
| Antiviral | Yes |
| Prediction | 0.565766 |